This document examines the impact of pharmacogenomic/pharmacogenetic information on the regulatory process in oncology.

Keywords: Pharmacogenetics, pharmacogenomics, oncology, polymorphisms, metabolism enzymes, receptors

Current version

Reflection paper on pharmacogenomics in oncology

Draft: consultation closedReference Number: EMEA/CHMP/PGxWP/128435/2006

English (EN) (109.19 KB - PDF)

First published: Last updated:
View

Share this page